A San Francisco marketplace is quietly trying to do something American healthcare has resisted for decades: print a single, upfront price on a surgery, a chemo regimen, a rehab. Then honor it.
Right now, somewhere in Ohio, an HR director is opening a spreadsheet that contains a number she cannot explain to her CFO. It's the line item for last quarter's spine surgeries. The number is not wrong, exactly. It is simply the sum of dozens of bills - imaging, anesthesia, hospital fees, surgeon fees, post-op care - that arrived at different times, from different vendors, in different formats. She is going to spend her afternoon making that number look like a budget.
Carrum Health is the company that wants to put one number in that cell.
Founded in 2014, headquartered in San Francisco, around 220 people deep, Carrum operates a marketplace that hooks self-insured employers up to a curated list of regional hospitals and physician groups. The pitch sounds almost embarrassingly simple: a single bundled price for a planned procedure, paid upfront, covering everything from the pre-op imaging to the rehab visit eight weeks later. No surprise bills. No itemized line items. No carefully worded apologies from a billing department.
American healthcare runs on a payment model called fee-for-service. It pays providers for procedures performed, not outcomes delivered. It is a system that has produced, among other things, the most expensive healthcare per capita in the developed world and a national pastime of arguing with insurance companies. It is also, charmingly, the system most large employers are still using to insure their workforces.
Sach Jain saw this up close. Before Carrum, he was a consultant at Booz & Company, where his job involved helping payers adapt to the post-ACA push toward value-based care - the wonky term for the idea that healthcare should be paid for in proportion to whether the patient gets better. He was, in other words, paid to study a problem from a polite distance.
In 2014, he decided polite distance was not getting it done.
Carrum's wager was that someone, eventually, would have to make the alternative real - not a pilot, not a working group, but an actual marketplace where the trade happens. The buyer would be the self-insured employer (large, capital-rich, motivated by spiraling premiums). The seller would be the Center of Excellence - the regional hospital with a knee-replacement surgeon who does eight a week and a complication rate well below the national mean.
Between them: a bundled contract. One price. Outcomes warrantied. If something goes wrong inside the recovery window, the provider eats the cost of fixing it. The cynic's read on this is that surgeons hate it. The cynic is partially right. The optimist's read is that the good ones don't, because the good ones already do excellent work and would rather be paid for being good than be paid for doing more.
Carrum sells three things that look like one thing. The Surgical Care program handles the planned-procedure menu: musculoskeletal (knees, hips, spine), cardiac, bariatric, and the long tail of episodes that show up on every benefits committee's "high spend" slide. The Cancer Care program, which exploded out of the Series B announcement in 2023, now covers near-comprehensive treatment across 400-plus facilities. The Substance Use Disorder program is the quietest of the three and possibly the most consequential, given who needs it and how badly the existing system serves them.
All three share the same shape: a member opens the Carrum app, gets matched with a top-tier provider in their region (or, when necessary, on the other side of the country with travel paid), works with a care navigator through scheduling and prep, has the procedure, recovers, closes the file. There is no second bill. There is no third bill. There is, ideally, no bill at all the patient ever sees. That is, in 2026, a radical product.
Marketplaces work or they don't, and the way you know is whether anyone is showing up to transact. Carrum has 400-plus self-insured employer groups in its book - companies ranging from under a thousand employees to north of 180,000. On the supply side, the cancer network alone grew five-fold in eighteen months. That is not a model assumption. That is a hospital business development team agreeing to share risk on outcomes, which they historically prefer not to do, repeated 400-plus times.
The partner list reads less like a roster and more like a small thesis on where employer benefits are heading. Quantum Health, the navigation giant, picked Carrum in 2024 as both its exclusive Premier Oncology partner and a Preferred Partner for surgical Centers of Excellence. Color Health stitched its Virtual Cancer Clinic into Carrum's COE network the same year. GRAIL handles multi-cancer early detection on the front end; AccessHope provides remote second opinions. The Oncology Institute and New England Cancer Specialists signed regional value-based deals for breast cancer care in Nevada and Maine, respectively.
Sach Jain has said, in roughly these words, that the company's job is to move healthcare away from the perils of fee-for-service and toward something a thoughtful person could defend. That is a mission statement and also, conveniently, the unit economics. Every bundle Carrum sells is a small bet that a region, a procedure, and a patient can be matched to a provider who will do the work for a fixed price and stand behind the result. Multiply that bet by 400 employers and a workforce in the millions, and you have something that looks less like a startup and more like infrastructure.
The competitive set is real. Transcarent, Lantern, Included Health, the direct-to-employer programs run by Cleveland Clinic and Mayo - all are circling the same insight. Carrum's distinctive bet is that the marketplace itself, the connective tissue between buyer and seller, is the durable asset. Anyone can negotiate a single bundle. Running hundreds of them, with care navigation and outcomes warranty layered on, is the harder problem.
Healthcare spend in the United States is on a glide path toward something around twenty percent of GDP. Employers - the ones who shoulder the cost of insuring more than 150 million working-age Americans - are running out of room to swallow premium increases without doing something different. "Something different" has been the official slogan of healthcare reform for two decades, and the result has mostly been more reform conferences. Carrum is one of the small number of companies that responded to the slogan by building a thing that, if it scales, makes the bill smaller and the outcomes better at the same time.
That is the kind of work that is unglamorous until it is suddenly inevitable. Bundled payments, transparent pricing, outcomes warranty - these are not new ideas. They have been argued for, written about, demonstrated in pilots, and largely ignored at the system level. The interesting question about Carrum is not whether their model works for a single knee replacement. We know it does. The interesting question is whether the marketplace itself reaches the scale at which it becomes the default - the boring, expected way an employer buys a surgery.
The HR director in Ohio. The cell she couldn't explain. Imagine the version of that afternoon where her company is on Carrum. The spreadsheet has a line for "knee bundle, 14 episodes, fixed contracted rate." The number is the same every quarter. The CFO does not ask a follow-up question. The director closes the file at 3:15 and goes to a meeting about literally anything else.
That is the small, unspectacular victory Carrum Health is selling. Not a moonshot. Not a manifesto. A predictable line on a spreadsheet, multiplied by every self-insured employer in the country. It is the kind of progress that, if it keeps compounding, eventually shows up in the only chart that matters: the one where U.S. healthcare costs stop bending in the wrong direction.
Carrum, for now, is one of the lines bending it back.